Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
428.90
-5.41 (-1.25%)
May 20, 2026, 3:05 PM EDT - Market open
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
32
Consensus Rating
Buy
Price Target
$541.22
Upside
+26.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $607 → $615 | Buy | Maintains | $607 → $615 | +43.39% | May 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $437 → $436 | Hold | Maintains | $437 → $436 | +1.66% | May 5, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $612 → $616 | Buy | Maintains | $612 → $616 | +43.62% | May 5, 2026 |
| Bernstein | Bernstein | Buy Maintains $577 → $572 | Buy | Maintains | $577 → $572 | +33.36% | May 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $541 → $543 | Buy | Maintains | $541 → $543 | +26.60% | May 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $441 → $437 | Hold | Maintains | $441 → $437 | +1.89% | Apr 30, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $596 → $612 | Buy | Maintains | $596 → $612 | +42.69% | Apr 10, 2026 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $575 | Hold → Strong Buy | Upgrades | $575 | +34.06% | Mar 18, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $490 → $525 | Strong Buy | Maintains | $490 → $525 | +22.41% | Mar 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $570 → $596 | Buy | Maintains | $570 → $596 | +38.96% | Mar 10, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $571 → $598 | Strong Buy | Maintains | $571 → $598 | +39.43% | Mar 10, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $575 → $585 | Strong Buy | Maintains | $575 → $585 | +36.40% | Mar 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $540 → $600 | Buy | Maintains | $540 → $600 | +39.89% | Mar 10, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $580 | Strong Buy | Initiates | $580 | +35.23% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $591 → $641 | Strong Buy | Maintains | $591 → $641 | +49.45% | Mar 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $411 → $441 | Hold | Maintains | $411 → $441 | +2.82% | Feb 17, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.